Bone Biologics Corporation (BBLG)
NASDAQ: BBLG · Real-Time Price · USD
1.800
-0.150 (-7.69%)
At close: Dec 24, 2025, 1:00 PM EST
1.730
-0.070 (-3.89%)
After-hours: Dec 24, 2025, 4:41 PM EST
Bone Biologics Employees
Bone Biologics had 2 employees as of December 31, 2024. The number of employees did not change compared to the previous year.
Employees
2
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
n/a
Profits / Employee
-$1,973,032
Market Cap
3.27M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 2 | 0 | - |
| Dec 31, 2023 | 2 | 0 | - |
| Dec 31, 2022 | 2 | 0 | - |
| Dec 31, 2021 | 2 | 0 | - |
| Dec 31, 2020 | 2 | 1 | 100.00% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
BBLG News
- 2 days ago - Bone Biologics Improves Extension of rhNELL-1 Product Shelf Life to 24 Months - GlobeNewsWire
- 4 months ago - Bone Biologics CEO Issues Letter to Stockholders Highlighting Company Update and Outlook - Business Wire
- 4 months ago - Bone Biologics to Participate in the H.C. Wainwright Global Investment Conference - Business Wire
- 6 months ago - Bone Biologics Announces Closing of $5.0 Million Public Offering - Business Wire
- 6 months ago - Why Is Bone Biologics Stock Surging On Friday? - Benzinga
- 6 months ago - Bone Biologics Announces Pricing of $5.0 Million Public Offering - Business Wire
- 6 months ago - Bone Biologics Files Patent Application for Bone Regeneration Technology - Business Wire
- 6 months ago - Bone Biologics Regains Compliance with Nasdaq Continued Listing Requirements - Business Wire